Abstract
Cardiovascular disease (CVD) is the leading global cause of death, highlighting the urgent need for early, accurate, and interpretable diagnostic tools. However, many AI-based heart disease prediction models lack transparency, hindering their acceptance in clinical settings. This study proposes XAI-HD, a hybrid framework integrating machine learning (ML), deep learning (DL), and explainable AI (XAI) techniques for heart disease detection. The framework systematically addresses key challenges, including class imbalance, missing data, and feature inconsistency, through advanced preprocessing and class-balancing methods such as OSS, NCR, SMOTEN, ADASYN, SMOTETomek, and SMOTEENN. Comparative performance evaluations across multiple datasets (CHD, FHD, SHD) demonstrate that XAI-HD reduces classification error rates by 20–25% compared to traditional ML-based models, achieving superior accuracy, precision, recall, and F1-score. Additionally, SHAP and LIME-based feature importance analysis enhances model interpretability, fostering trust among medical professionals. The proposed framework holds significant real-world applicability, including seamless integration into hospital decision support systems, electronic health records (EHR), and real-time cardiac risk assessment platforms. Unlike conventional AI-driven cardiovascular risk prediction models, XAI-HD offers a more balanced, interpretable, and computationally efficient solution, ensuring both predictive accuracy and practical feasibility in clinical environments. Statistical validation using Wilcoxon signed-rank tests confirms the performance gains, and complexity analysis shows the framework is scalable for large-scale deployment.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 International University of Business Agriculture and Technology, Department of Computer Science and Engineering, Dhaka, Bangladesh (GRID:grid.443015.7) (ISNI:0000 0001 2222 8047)
2 Electronics Research Institute, Computers and Systems Department, Cairo, Egypt (GRID:grid.463242.5) (ISNI:0000 0004 0387 2680)
3 King Saud University, Department of Pharmaceutics, College of Pharmacy, Riyadh 11451, Saudi Arabia (GRID:grid.56302.32) (ISNI:0000 0004 1773 5396)
4 Deakin University, School of Information Technology, Burwood 3125, Australia (GRID:grid.1021.2) (ISNI:0000 0001 0526 7079)





